GlassScriptPhysician profile
Nicholas B Plants
NPI 1124346473
$9,353.22
in general payments reported to CMS, 2019-2025
21 companies · $895 in 2025
The $895 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $433 · 2021: $827 · 2022: $2,914 · 2023: $1,813 · 2024: $1,372 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,080.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,281.24 | 2021-2025 | |
| Stryker Corporation | $1,807.56 | 2019-2025 | Anchorage, Ortholoc 3di, Swanson |
| Smith+Nephew, INC. | $1,668.98 | 2019-2025 | Stravix, Grafix, Grafix Xc |
| Pylant Medical | $1,339.68 | 2019-2024 | |
| Organogenesis INC. | $473.53 | 2019-2022 | |
| Tenex Health INC. | $319.83 | 2020-2021 | |
| Nevro Corp. | $293.43 | 2022-2024 | Senza |
| Medtronic, INC. | $255.16 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Next Science LLC | $194.03 | 2022-2023 | Surgx, Xperience, Blastx |
| Averitas Pharma INC. | $148.10 | 2024-2025 | Qutenza |
| Angiodynamics, INC. | $147.14 | 2022 | |
| Depuy Synthes Sales INC. | $105.42 | 2020 | |
| Paratek Pharmaceuticals, INC. | $78.68 | 2024-2025 | Nuzyra |
| Convatec INC. | $74.96 | 2023 | |
| Globus Medical, INC. | $43.13 | 2025 | Senza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $35.67 | 2023 | |
| Curonix LLC | $22.37 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Reprise Biomedical, INC. | $21.45 | 2025 | Miro3d |
| Grt US Holding, INC. | $16.76 | 2021 | |
| Kerecis Limited | $13.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Wright Medical Technology, INC. | $12.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Plants listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.